In vitro cardiac new approach methodologies predict clinical cardiovascular repolarization risk comparable to non-clinical animal studies

Download

Authors: Natalie E. Simpson, Tromondae K. Feaster, Ksenia Blinova, and Nakissa Sadrieh

British Journal of Pharmacology, 04 June 2026

Related Resources
The NAMs Inflection Point: Building a Future-Proof Safety Strategy With Maestro MEA
Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study
From Stem Cell Models to Trusted NAMs: How Functional Assays Support Drug Development Decisions

Related Products

System

Axion MEA

MEA and HD-MEA systems for advanced electrophysiology

Learn more >>
Axion MEA family - Synexus, Maestro Pro, Maestro Edge and Maestro Volt
System

Maestro Pro

High-throughput MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Pro MEA system
Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments
Consumable

CytoView MEA Plate

The premium Maestro MEA plate with a transparent well bottom for cell visualization and assay multiplexing

Learn more >>
Axion BioSystems CytoView MEA plate